Park Medi World

    PARKHOSPS
    Pharma
    ₹238.04
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹10,282 Cr

    P/E
    38.96
    Day range
    ₹235.76 – ₹241.16
    52-week range
    ₹138.10 – ₹305.00
    Volume
    4.83 L
    Open
    ₹240.01
    Prev close
    ₹240.01

    Latest results · Q2 FY27(consolidated)Revenue ₹511 CrProfit ₹54 CrMargin 10.7%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 51 / 100

    Factor percentiles

    Value48
    Quality61
    Momentum40
    Low volatility54

    Derived metrics

    Earn. yield
    2.6%
    Graham no.
    ₹80.52
    vs Graham
    -66.2%
    ROE ÷ P/B
    3.6%
    Magic Formula
    #317
    FCF yield
    2.0%

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 68 in Pharma
    Largest Pharma companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Sun PharmaSUNPHARMA₹4.49 L Cr40.955.0314.8%21.0%29.0%0.04+11.9%
    Divi's LaboratoriesDIVISLAB₹2.93 L Cr87.1916.8816.2%22.0%43.0%0.00+35.4%
    Torrent PharmaTORNTPHARM₹1.75 L Cr77.889.6726.8%15.0%33.0%0.77+50.8%
    Apollo HospitalsAPOLLOHOSP₹1.27 L Cr56.4011.5522.6%17.0%16.0%0.77+23.0%
    Laurus LabsLAURUSLABS₹1.25 L Cr93.7219.8218.2%18.0%34.0%0.43+33.5%
    Zydus LifesciencesZYDUSLIFE₹1.20 L Cr28.724.3220.1%21.0%24.0%0.50+29.2%
    Dr. Reddy's LabsDRREDDY₹1.17 L Cr41.632.9711.6%13.0%20.0%0.19-1.5%
    Park Medi WorldPARKHOSPS₹10,282 Cr38.964.9017.8%19.0%20.0%0.26+24.6%
    Sector median₹24,603 Cr43.685.4615.1%17.0%24.0%0.17+22.7%

    Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 7h ago

    Headlines about Park Medi World from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    41.3
    Price / Book
    4.76
    ROE (FY26)
    17.8%
    ROCE (latest year)
    19%
    Dividend yield
    0.00%

    Moving averages (NSE)

    20-day
    ₹235.15
    Price above
    50-day
    ₹256.37
    Price below
    200-day
    ₹245.23
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +10.2%
    Profit 3Y CAGR
    +6.3%
    Revenue YoY (Sep 2026)
    +24.6%
    Profit YoY (Sep 2026)
    -31.6%
    Operating margin
    20.0%
    Net margin
    10.6%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr200 Cr400 Cr600 Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 20260%15%30%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • DII
    • Public
    • FII
    • Government

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-400 Cr-200 Cr0 Cr200 Cr400 Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY22FY23FY24FY25FY260%20%40%60%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr1K Cr2K Cr3K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 20260x1x2x

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales348354399410410460476511
    Expenses265265294297311333350409
    Operating Profit838810511399127126102
    OPM %24%25%26%27%24%28%26%20%
    Other Income1597898810
    Interest1616151515141014
    Depreciation1516151515181921
    Profit before tax676682917810310576
    Tax %32%20%20%14%32%26%16%29%
    Net Profit4652667953778954
    EPS in Rs₹1.19₹1.17₹1.51₹1.91₹1.17₹1.64₹1.91₹1.21

    From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days129

    -22 days since Mar 2021

    Inventory Days4

    -43 days since Mar 2021

    Days Payable134

    +13 days since Mar 2021

    Cash Conversion Cycle-2

    -79 days since Mar 2021

    Working Capital Days28

    -12 days since Mar 2021

    Strengths, risks & growth

    Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320)

    Strengths

    None flagged by the checklist.

    Risks

    • Though the company is reporting repeated profits, it is not paying out dividend

    Compounded Sales Growth

    10 Years
    —
    5 Years
    +17%
    3 Years
    +10%
    TTM
    +23%

    Compounded Profit Growth

    10 Years
    —
    5 Years
    +11%
    3 Years
    +5%
    TTM
    +15%

    Return on Equity

    10 Years
    —
    5 Years
    +24%
    3 Years
    +19%
    Last Year
    +17%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter82.89%82.89%82.89%82.89%0.00 pp
    FII1.28%0.86%0.82%0.88%+0.06 pp
    DII8.58%8.95%8.95%8.23%-0.72 pp
    Government0.20%0.30%0.00%0.00%0.00 pp
    Public7.06%6.98%7.33%8.00%+0.67 pp

    Filed with NSE for Sept 2026: promoters 82.90%, public 17.10%

    Analysts & fund holdings

    100%
    100% recommend buy
    2 analysts cover the stock
    Valuation vs Health Care Providers & Services
    P/E39.0 vs 45.1
    Sector P/B6.03

    Who holds the shares, quarter by quarter

    Mutual funds 5.39% (-0.27 pp)
    Mar 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters82.9%
    • Foreign institutions0.9%
    • Mutual funds5.4%
    • Insurance0.4%
    • Other domestic institutions2.5%
    • Retail3.0%
    • Others5.0%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    Kotak Multi Asset Allocation Fund1.90%1.34%-0.44 pp
    Kotak Contra Fund0.71%1.45%-0.35 pp
    Kotak ELSS Tax Saver Fund0.56%0.97%-0.24 pp
    Kotak Consumption Fund0.43%2.67%-1.09 pp
    Kotak Special Opportunities Fund0.33%1.91%-1.19 pp

    Scorecard

    Performance
    Avg
    Valuation
    High
    Growth
    Low
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 226 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    42.7%
    Downside volatility
    38.3%
    Worst 5% of days
    4.2%
    Average of that tail
    5.5%
    Max drawdown (1Y)
    28.1%
    Below its peak
    20.5%

    Against the market

    Beta vs Nifty 50
    0.82
    Correlation
    0.29
    Relative strength (3M)
    -17.8%
    ATR (14)
    4.9%

    Return

    Return 1M
    +1.0%
    Return 3M
    -14.0%
    Return 6M
    -0.7%
    Return 1Y
    —
    vs 200-day average
    -2.9%

    Momentum

    RSI (14)
    45.2
    MACD histogram
    2.18
    Stochastic %K
    42.1
    ADX (14)
    32.7
    +DI / −DI
    19.7 / 30.0
    Money flow index
    21.5

    Participation

    Delivery (20d avg)
    49.1%
    vs its 60-day baseline
    -3.9 pts
    Volume vs 20-day
    -0.3σ
    Close vs day's VWAP
    +0.3%
    52-week position
    61 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 31 Mar 2026.

    Computed

    No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.

    Free cash flow
    ₹209 Cr
    FCF yield
    2.0%
    Net debt
    ₹127 Cr
    Net debt / equity
    0.06
    EV / sales
    5.61

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Corporate actions

    No dividends, splits or bonuses recorded for this company yet.

    Company announcements

    Company Update
    Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

    Company Update
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

    Insider Trading / SAST
    Closure of Trading Window

    Intimation regarding closure of trading window

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting Results and Consolidated Scrutinizer's Report on E-voting at 15th Annual General Meeting held on September 22, 2026

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Summary of the proceedings of 15th Annual General Meeting of the Company held on September 22, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Press Release titled Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Cancellation of Schedule of Investor/Analyst Meeting

    Company Update
    Operations And Management Agreement With Axis Educational Society

    Wholly-owned subsidiary of the Company has entered into operation and management agreement with Axis Educational Society

    Company UpdatePrice-sensitive
    Announcement under Regulation 30 (LODR)-Acquisition

    Incorporation of Wholly Owned Subsidiary

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Meeting with Analysts/Investors

    AGM/EGM
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Voting results with respect to Postal Ballot notice dated August 03, 2026

    Company UpdatePrice-sensitive
    Announcement under Regulation 30 (LODR)-Acquisition

    Incorporation of Wholly Owned Subsidiary

    Others
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 31, 2026

    Outcome of Board Meeting held on August 31, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Advertisement regarding Notice of the 15th AGM containing e-voting information and dispatch details

    Company Update
    Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2026

    Letter to the Shareholders containing weblink of Annual Report and Notice of AGM for the Financial year 2025-2026

    Filed with BSE (scrip 544645); the last 45 days. Documents open at bseindia.com.

    Documents

    Annual reports

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 13 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Park Medi World: common questions

    Answered from the figures on this page.

    Park Medi World last traded at ₹238.04 (NSE, as of 18 Nov 2026). The last session moved it down 0.82%.

    Park Medi World is valued at about ₹10,282 crore (NSE, as of 18 Nov 2026).

    Park Medi World trades at a price-to-earnings ratio of 38.96 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Park Medi World has traded between ₹138.10 and ₹305.00 over the past 52 weeks, to 18 Nov 2026. It is currently 60% of the way up that range.

    Park Medi World (PARKHOSPS) is classified under Pharma on this site's screener.